Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001453687-24-000124
Filing Date
2024-11-07
Accepted
2024-11-07 07:19:19
Documents
107
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rnac-20240930.htm   iXBRL 10-Q 1525854
2 EX-10.1 ex101secondamendmenttoleas.htm EX-10.1 59405
3 EX-31.1 exhibit311_9302024.htm EX-31.1 10324
4 EX-31.2 exhibit312_9302024.htm EX-31.2 10266
5 EX-32.1 exhibit321_9302024.htm EX-32.1 9955
  Complete submission text file 0001453687-24-000124.txt   9921368

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240930.xsd EX-101.SCH 83311
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnac-20240930_cal.xml EX-101.CAL 85228
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnac-20240930_def.xml EX-101.DEF 499850
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20240930_lab.xml EX-101.LAB 904890
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20240930_pre.xml EX-101.PRE 724235
110 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240930_htm.xml XML 1297386
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37798 | Film No.: 241433164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)